1
Enquiry period
with 09.01.2023 17:20
to 19.01.2023 11:00
2
Bidding period
with 19.01.2023 11:00
to 25.01.2023 13:00
3
Auction
26.01.2023 14:00
4
Evaluation

5
Contract

Status Evaluation
Estimated value without VAT 869 837,47 MDL
Period of clarifications: 9 Jan 2023, 17:20 - 19 Jan 2023, 11:00
Submission of proposals: 19 Jan 2023, 11:00 - 25 Jan 2023, 13:00

Supplier technical support:

(+373) 79999801

“Achiziţionarea medicamentelor pentru Boala Addison în scopul realizării Programului Național ”Combatarea maladiilor rare” pentru anul 2023, repetat 3”

Information about customer
Fiscal code/IDNO
Address
MD-2009, MOLDOVA, mun.Chişinău, locality, MD-2009, Republica Moldova, Chişinău str. Cosmescu 3
Web site
---
The contact person
Full name
Macari Doina
Contact phone
+37322222490
Purchase data
Date created
9 Jan 2023, 17:09
Date modified
9 Jan 2023, 17:20
Achizitii.md ID
21071311
CPV
33600000-6 - Produse farmaceutice
Type of procedure
Open tender
Award criteria
The lowest price
Funding sources
List of lots
Lot nr. 1 - Cortisonum 25 mg
Budget: 532554.23 MDL
Active
Lot nr. 3 - Hydrocortisonum 20 mg
Budget: 283617.05 MDL
Purchase has not taken place
Documents of the procurement procedure
Declaratie privind valabilitatea ofertei_Model
Bidding Documents
Declaratie privind valabilitatea ofertei_Model
9.01.23 17:20
DUAE Model
Bidding Documents
DUAE Model
9.01.23 17:20
Cerere de participare_Model
Bidding Documents
Cerere de participare_Model
9.01.23 17:20
Declaratie beneficiari efectivi_Model
Bidding Documents
Declaratie beneficiari efectivi_Model
9.01.23 17:20
Propunerea tehnică
Technical Specifications
Propunerea tehnică
9.01.23 17:20
Anunt de participare A.signed
Bidding Documents
Anunt de participare
9.01.23 17:20
Scrisoare de garantie bancara_Model
Bidding Documents
Scrisoare de garantie bancara_Model
9.01.23 17:20
Documentatia standard A.signed
Bidding Documents
Documentatia standard
9.01.23 17:20
Propunerea financiară
Technical Specifications
Propunerea financiară
9.01.23 17:20
Only authorized platform users may ask questions during the clarification period.